Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
Charles River Laboratories
CRL
$12.8B
| $1.28M | ﹤0.01% |
8,393
+4,000
| +91% | +$554K |
|
3402
Griffon
GFF
$4.88B
| $1.28M | ﹤0.01% |
63,130
+19,820
| +46% | +$417K |
|
3403
WillScot Mobile Mini Holdings
WSC
$4.67B
| $1.28M | ﹤0.01% |
69,351
+43,889
| +172% | +$737K |
|
3404
PUT
Direxion Daily Technology Bull 3x ETF
TECL
$5.97B
| $1.28M | ﹤0.01% |
53,000
+37,000
| +231% | +$735K |
|
|
PRNB
3405
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.28M | ﹤0.01% |
23,408
+13,162
| +128% | +$491K |
|
3406
Northern Oil and Gas
NOG
$2.21B
| $1.28M | ﹤0.01% |
54,650
+15,198
| +39% | +$301K |
|
3407
CALL
iShares MSCI Turkey ETF
TUR
$213M
| $1.28M | ﹤0.01% |
47,200
+22,800
| +93% | +$589K |
|
3408
CALL
Fluor
FLR
$6.81B
| $1.28M | ﹤0.01% |
67,700
+6,200
| +10% | +$113K |
|
3409
PUT
Vornado Realty Trust
VNO
$7.27B
| $1.28M | ﹤0.01% |
19,200
-41,100
| -68% | -$2.66M |
|
|
GRA
3410
DELISTED
W.R. Grace & Co.
GRA
| $1.28M | ﹤0.01% |
18,285
-48,197
| -72% | -$3.23M |
|
3411
CALL
Murphy Oil
MUR
$4.74B
| $1.28M | ﹤0.01% |
47,600
+18,200
| +62% | +$417K |
|
3412
RadNet
RDNT
$5.36B
| $1.28M | ﹤0.01% |
62,830
+35,859
| +133% | +$615K |
|
3413
PUT
Trupanion
TRUP
$1.23B
| $1.27M | ﹤0.01% |
+34,000
| New | +$999K |
|
3414
ArcBest
ARCB
$3.02B
| $1.27M | ﹤0.01% |
46,098
+10,523
| +30% | +$304K |
|
3415
Aecom
ACM
$9.63B
| $1.27M | ﹤0.01% |
29,474
-170,064
| -85% | -$7.05M |
|
3416
MKS Inc
MKSI
$19.7B
| $1.27M | ﹤0.01% |
11,564
-44,941
| -80% | -$4.71M |
|
3417
CorVel
CRVL
$3.19B
| $1.27M | ﹤0.01% |
43,686
-2,226
| -5% | -$59.2K |
|
3418
1st Source
SRCE
$2.15B
| $1.27M | ﹤0.01% |
24,497
+6,903
| +39% | +$347K |
|
|
MODN
3419
DELISTED
MODEL N, INC.
MODN
| $1.27M | ﹤0.01% |
36,167
-4,219
| -10% | -$128K |
|
3420
MACOM Technology Solutions
MTSI
$23B
| $1.26M | ﹤0.01% |
47,420
-2,063
| -4% | -$49.3K |
|
3421
PUT
Elanco Animal Health
ELAN
$12.1B
| $1.26M | ﹤0.01% |
42,700
-25,100
| -37% | -$682K |
|
|
TRST
3422
Trustco Bank Corp NY
TRST
$958M
| $1.26M | ﹤0.01% |
29,033
+9,573
| +49% | +$410K |
|
3423
Rayonier
RYN
$6.45B
| $1.26M | ﹤0.01% |
42,252
-36,047
| -46% | -$982K |
|
|
MSGN
3424
DELISTED
MSG Networks Inc.
MSGN
| $1.26M | ﹤0.01% |
72,234
-316,500
| -81% | -$5.27M |
|
|
BRSL
3425
PUT
Brightstar Lottery PLC
BRSL
$2.03B
| $1.25M | ﹤0.01% |
83,700
+500
| +0.6% | +$7.12K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.